HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong Miao Selected Research

Alopecia (Baldness)

10/2022Current application of mesotherapy in pattern hair loss: A systematic review.
8/2022Efficacy assessment for low-level laser therapy in the treatment of androgenetic alopecia: a real-world study on 1383 patients.
8/2022Correction to: Efficacy assessment for low‑level laser therapy in the treatment of androgenetic alopecia: a real‑world study on 1383 patients.
2/2022Overexpression of miR-122 promotes apoptosis of dermal papilla cells by directly targeting IGF1R in androgenetic alopecia.
10/2021Platelet-rich plasma for androgenic alopecia: A randomized, placebo-controlled, double-blind study and combined mice model experiment.
7/2021Comparison of low-level light therapy and combination therapy of 5% minoxidil in the treatment of female pattern hair loss.
6/2021Proposed mechanisms of low-level light therapy in the treatment of androgenetic alopecia.
5/2021Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia.
3/2021The effect of hyperbaric oxygen therapy combined with hair transplantation surgery for the treatment of alopecia.
3/2021Impairment of autophagy may be associated with follicular miniaturization in androgenetic alopecia by inducing premature catagen.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong Miao Research Topics

Disease

20Alopecia (Baldness)
10/2022 - 12/2018
2Inflammation (Inflammations)
01/2021 - 09/2019
1Postoperative Pain
10/2022
1Necrosis
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Reperfusion Injury
03/2021
1Folliculitis (Sycosis)
03/2021
1Pruritus (Itching)
03/2021
1Nausea
11/2020
1Dizziness (Lightheadedness)
11/2020
1Orthostatic Hypotension (Postural Hypotension)
11/2020
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2020
1AIDS-Related Complex (ARC)
08/2020
1Cicatrix (Scar)
02/2020
1Tissue Adhesions
01/2018
1Wounds and Injuries (Trauma)
01/2018
1Nasopharyngeal Carcinoma
02/2015
1Cysts
01/2012
1Autosomal Recessive Primary Microcephaly
01/2010
1Cholangitis
11/2009

Drug/Important Bio-Agent (IBA)

2AndrogensIBA
02/2022 - 01/2021
2Messenger RNA (mRNA)IBA
10/2020 - 11/2009
1SolutionsIBA
10/2022
1Ropivacaine (Naropin)FDA LinkGeneric
10/2022
1Minoxidil (Rogaine)FDA LinkGeneric
07/2021
1Dihydrotestosterone (Androstanolone)IBA
05/2021
1Androgen Receptors (Androgen Receptor)IBA
05/2021
1Melanins (Melanin)IBA
01/2021
1CytokinesIBA
01/2021
1CollagenIBA
01/2021
1veratric acidIBA
01/2021
1hydroxide ionIBA
11/2020
1Methotrexate (Mexate)FDA LinkGeneric
10/2020
1Adalimumab (Humira)FDA Link
10/2020
1Etanercept (Enbrel)FDA Link
10/2020
1tofacitinibIBA
10/2020
1Therapeutic UsesIBA
01/2020
1HydrogelsIBA
01/2020
13,4-dihydroxyphenylethanol (hydroxytyrosol)IBA
09/2019
1AntioxidantsIBA
09/2019
1Biological ProductsIBA
09/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2019
1GelsIBA
01/2018
1Eosine Yellowish-(YS) (Eosin)IBA
01/2012
1Proteins (Proteins, Gene)FDA Link
01/2010
1Triggering Receptor Expressed on Myeloid Cells-1IBA
11/2009

Therapy/Procedure

7Transplantation
01/2022 - 12/2018
7Therapeutics
10/2021 - 01/2020
3Low-Level Light Therapy (LLLT)
08/2022 - 06/2021
1Local Anesthesia
10/2022
1Anesthesia
10/2022
1Mesotherapy
10/2022
1Laser Therapy (Surgery, Laser)
08/2022
1Hyperbaric Oxygenation
03/2021
1Precision Medicine
10/2020
1Surgical Instruments (Clip)
08/2020
1Sutures (Suture)
01/2018
1Radiotherapy
02/2015
1Intradermal Injections
01/2012